James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...
Alexandria Real Estate Equities (NYSE:ARE) reported its fourth-quarter 2024 earnings, revealing a significant miss in earnings per share (EPS) compared to analyst expectations. The company posted an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback